Sage Bionetworks

Apple to launch new software framework CareKit

Thursday, March 24, 2016

Apple is launching CareKit, a new software framework designed to help developers enable people to actively manage their own medical conditions. iPhone apps using CareKit make it easier for individuals to keep track of care plans and monitor symptoms and medication; providing insights that help people better understand their own health. With the ability to share information with doctors, nurses or family members, CareKit apps help people take a more active role in their health.

[Read More]

Smartphone app revolutionizes clinical trial consent and data sharing

Monday, March 14, 2016

Sage Bionetworks, a Seattle-based nonprofit, has released the first six months of data from a new iPhone app that captures the everyday experiences of more than 9,500 study participants. The app, called mPower (Mobile Parkinson’s Observatory for Worldwide, Evidence-based Research), manages and simplifies the research study, from patient recruitment through the enrollment and consent process. It also enables researchers to collect extensive data from patients with and without Parkinson’s disease. Data from the study can be used to assess the ability of mobile apps to improve the paradigm for clinical studies.

[Read More]

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Monday, March 23, 2015

Apple has taken a key step this month toward helping to improve patient recruitment for medical studies with ResearchKit, a new iPhone-based medical software platform researchers can use to de­sign and administer app-based observational studies. ResearchKit will help both doctors and researchers gather patient data frequently and more accurately track disease signs using sen­sors that are on the iPhone.

[Read More]

NIH-led effort launches Big Data portal for Alzheimer’s drug discovery

Friday, March 6, 2015

A NIH-led public-private partnership to transform and accelerate drug development has launched a new Alzheimer’s Big Data portal—including delivery of the first wave of data—for use by the research community. The new data sharing and analysis resource is part of the Accelerating Medicines Partnership (AMP), an unprecedented venture bringing together NIH, FDA, industry and academic scientists from a variety of disciplines to translate knowledge faster and more successfully into new therapies.

[Read More]